KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Encompass Health (EHC) Operating Leases (2019 - 2026)

Encompass Health (EHC) has disclosed Operating Leases for 8 consecutive years, with $188.7 million as the latest value for Q1 2026.

  • For Q1 2026, Operating Leases fell 7.59% year-over-year to $188.7 million; the TTM value through Mar 2026 reached $188.7 million, down 7.59%, while the annual FY2025 figure was $196.6 million, 3.64% up from the prior year.
  • Operating Leases hit $188.7 million in Q1 2026 for Encompass Health, down from $196.6 million in the prior quarter.
  • Across five years, Operating Leases topped out at $211.9 million in Q2 2022 and bottomed at $183.3 million in Q3 2022.
  • Average Operating Leases over 5 years is $196.5 million, with a median of $196.6 million recorded in 2025.
  • On a YoY basis, Operating Leases climbed as much as 11.19% in 2022 and fell as far as 12.04% in 2022.
  • Encompass Health's Operating Leases stood at $199.7 million in 2022, then fell by 1.8% to $196.1 million in 2023, then fell by 3.26% to $189.7 million in 2024, then rose by 3.64% to $196.6 million in 2025, then decreased by 4.02% to $188.7 million in 2026.
  • According to Business Quant data, Operating Leases over the past three periods came in at $188.7 million, $196.6 million, and $202.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.